tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYAD

Celyad Oncology announces receipt of Nasdaq delisting notice
Press ReleasesCelyad Oncology announces receipt of Nasdaq delisting notice
12M ago
CYAD
Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq
PremiumPress Releases
Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq
12M ago
CYAD
Celyad Oncology reports first quarter 2023 financial results and recent business highlights
PremiumPress Releases
Celyad Oncology reports first quarter 2023 financial results and recent business highlights
12M ago
CYAD
Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price
PremiumPress Releases
Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price
1y ago
CYAD
Celyad receives Nasdaq initial notification on ADS bid price
PremiumThe Fly
Celyad receives Nasdaq initial notification on ADS bid price
1y ago
CYAD
Celyad Oncology announces receipt of Nasdaq notice
PremiumPress ReleasesCelyad Oncology announces receipt of Nasdaq notice
1y ago
CYAD
Celyad receives noncompliance letter from Nasdaq
PremiumThe Fly
Celyad receives noncompliance letter from Nasdaq
1y ago
CYAD
Celyad discloses Nasdaq listing notice
PremiumThe Fly
Celyad discloses Nasdaq listing notice
1y ago
CYAD
Celyad names Georges Rawadi as new CEO
PremiumThe Fly
Celyad names Georges Rawadi as new CEO
1y ago
CYAD
Celyad Oncology appoints Georges Rawadi as its new CEO
PremiumPress Releases
Celyad Oncology appoints Georges Rawadi as its new CEO
1y ago
CYAD
Celyad Oncology reports full year 2022 financial results and recent business highlights
PremiumPress Releases
Celyad Oncology reports full year 2022 financial results and recent business highlights
1y ago
CYAD
Celyad Oncology to announce full year 2022 financial results and host conference call
PremiumPress Releases
Celyad Oncology to announce full year 2022 financial results and host conference call
1y ago
CYAD
Celyad to recognize non-cash impairment of EUR 35.1M for FY22
PremiumThe FlyCelyad to recognize non-cash impairment of EUR 35.1M for FY22
1y ago
CYAD
Celyad Oncology announces non-cash impairment
PremiumPress Releases
Celyad Oncology announces non-cash impairment
1y ago
CYAD
REPEAT — Celyad Oncology SA – Letter to Shareholders
PremiumPress Releases
REPEAT — Celyad Oncology SA – Letter to Shareholders
1y ago
CYAD
Celyad to entirely focus on new business strategy
PremiumThe Fly
Celyad to entirely focus on new business strategy
1y ago
CYAD
Celyad Oncology SA – Letter to Shareholders
PremiumPress Releases
Celyad Oncology SA – Letter to Shareholders
1y ago
CYAD
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
AUTL
AVRO
Celyad poblishes data from haematological arm of THINK study
PremiumThe Fly
Celyad poblishes data from haematological arm of THINK study
1y ago
CYAD
Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01
PremiumPress ReleasesCelyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01
1y ago
CYAD
Lava Therapeutics appoints Charles Morris as CMO
PremiumThe Fly
Lava Therapeutics appoints Charles Morris as CMO
1y ago
CYAD
LVTX
Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook
PremiumPress Releases
Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook
1y ago
CYAD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >